RecruitingNot ApplicableNCT06027996

Melodi Matrix™ in Breast Reconstruction

Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction With Infection Outcomes Assessment (ARIA)


Sponsor

Melodi Health, Inc.

Enrollment

702 participants

Start Date

Aug 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Prospective, multicenter, randomized, controlled trial evaluating the safety and effectiveness of an absorbable antibacterial matrix device in two stage prepectoral alloplastic breast reconstruction.


Eligibility

Sex: FEMALEMin Age: 22 Years

Inclusion Criteria4

  • Female.
  • Age 22 or older at the time of enrollment.
  • Is scheduled to undergo unilateral or bilateral mastectomy (including prophylactic) with immediate two-stage post-mastectomy alloplastic prepectoral breast reconstruction.
  • Is able to and willing to comply with the study requirements and providing informed consent.

Exclusion Criteria11

  • Has prior history of neoadjuvant radiotherapy.
  • Has had prior history of failed tissue expansion or breast implantation at the intended reconstruction site.
  • Has an active abscess or infection requiring antibiotics anywhere in their body within 30 days.
  • Has a Body Mass Index (BMI) \< 14 or \> 40.
  • Is pregnant or is nursing; or plans to become pregnant during the course of the study.
  • Has any connective tissue/autoimmune disorder or rheumatoid disease.
  • Has known allergies to study device materials.
  • Is participating in another interventional research study that may interfere with study endpoints.
  • Has limited life expectancy or co-morbid conditions, social/psychological problems, or cognitive impairments that precludes participation.
  • Has a medical condition or is taking medications that would result in elevated risk and/or affect the validity of the study.
  • Intraoperative assessment demonstrates unfavorable conditions (i.e., poor mastectomy skin flap thickness or viability) for immediate, two-stage post-mastectomy alloplastic prepectoral reconstruction in any breast.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAbsorbable Antibacterial Matrix

Soft tissue support coated with antibiotics


Locations(10)

Stanford University

Palo Alto, California, United States

University of Michigan Health

Ann Arbor, Michigan, United States

Mayo Clinic

Rochester, Minnesota, United States

Northwell Health

Staten Island, New York, United States

The Ohio State University

Columbus, Ohio, United States

UPMC

Pittsburgh, Pennsylvania, United States

Medical University of South Carolina

Charleston, South Carolina, United States

Monument Health

Rapid City, South Dakota, United States

MD Anderson Cancer Center

Houston, Texas, United States

University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06027996


Related Trials